Community intervention for cardiovascular disease risk factors in Kalutara, Sri Lanka.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
28 04 2020
Historique:
received: 13 10 2019
accepted: 12 03 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 2 12 2020
Statut: epublish

Résumé

The effectiveness of a 2015-17 community intervention to reduce cardiovascular disease (CVD) and type 2 diabetes (T2DM) risk factors is assessed in a Sri Lanka adult population, using a before-and-after study design. Four contiguous Public Health Midwife (PHM) areas in Kalutara district (Western Province) were exposed to a Sri Lankan designed community health promotion initiatives (without screening) to lower CVD and T2DM risk factors. Pre- and post-intervention surveys (2014, n=1,019; 2017, n=908) were of 25-64 year males (M) and females (F) from dissimilar randomly selected clusters (villages or settlements) from PHMs, with probability of selection proportional to population size, followed by household sampling, then individual selection to yield equal-probability samples. Differences in resting blood pressure (BP), fasting plasma glucose (FPG), total cholesterol, body mass index and tobacco smoking, adjusting for cluster sampling, age and socio-economic differences, were examined. Hypertension prevalence declined from 25% to 16% (F) (p<.0001), and 21% to 17% (M). Both mean systolic and diastolic BP declined. T2DM declined from 18% to 13% (F), and 18% to 15% (M), as did mean fasting plasma glucose. Elevated total cholesterol declined from 21% to 15% in women (p=0.003) and mean cholesterol declined. Frequency distributions, medians and means of these continuous CVD risk factors shifted to lower levels, and were mostly statistically significant (p< 0.05). Community health promotion can lower key CVD and T2DM risk factors. Lowering tobacco consumption in males and obesity remain challenges in Sri Lanka.

Sections du résumé

BACKGROUND
The effectiveness of a 2015-17 community intervention to reduce cardiovascular disease (CVD) and type 2 diabetes (T2DM) risk factors is assessed in a Sri Lanka adult population, using a before-and-after study design.
METHODS
Four contiguous Public Health Midwife (PHM) areas in Kalutara district (Western Province) were exposed to a Sri Lankan designed community health promotion initiatives (without screening) to lower CVD and T2DM risk factors. Pre- and post-intervention surveys (2014, n=1,019; 2017, n=908) were of 25-64 year males (M) and females (F) from dissimilar randomly selected clusters (villages or settlements) from PHMs, with probability of selection proportional to population size, followed by household sampling, then individual selection to yield equal-probability samples. Differences in resting blood pressure (BP), fasting plasma glucose (FPG), total cholesterol, body mass index and tobacco smoking, adjusting for cluster sampling, age and socio-economic differences, were examined.
RESULTS
Hypertension prevalence declined from 25% to 16% (F) (p<.0001), and 21% to 17% (M). Both mean systolic and diastolic BP declined. T2DM declined from 18% to 13% (F), and 18% to 15% (M), as did mean fasting plasma glucose. Elevated total cholesterol declined from 21% to 15% in women (p=0.003) and mean cholesterol declined. Frequency distributions, medians and means of these continuous CVD risk factors shifted to lower levels, and were mostly statistically significant (p< 0.05).
CONCLUSIONS
Community health promotion can lower key CVD and T2DM risk factors. Lowering tobacco consumption in males and obesity remain challenges in Sri Lanka.

Identifiants

pubmed: 32345219
doi: 10.1186/s12872-020-01427-y
pii: 10.1186/s12872-020-01427-y
pmc: PMC7187517
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

203

Références

PLoS One. 2017 Jul 13;12(7):e0180640
pubmed: 28704405
Clin Exp Hypertens. 2014;36(7):484-91
pubmed: 24433043
Ann Fam Med. 2015 Aug;13 Suppl 1:S50-8
pubmed: 26304972
Int J Equity Health. 2012 Dec 13;11:76
pubmed: 23237051
Br Med J. 1964 Jun 6;1(5396):1460-7 CONCL
pubmed: 14132080
BMJ. 2003 Jun 28;326(7404):1423
pubmed: 12829554
JAMA. 2008 May 7;299(17):2037-47
pubmed: 18460664
BMC Public Health. 2014 Jun 25;14:644
pubmed: 24962316
Br Med J. 1964 May 30;1(5395):1399-410
pubmed: 14135164
Obes Rev. 2011 Nov;12 Suppl 2:12-9
pubmed: 22008555
Asia Pac J Public Health. 2012 Jul;24(4):663-71
pubmed: 22815304
Lancet. 2010 Nov 20;376(9754):1785-97
pubmed: 21074253
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Clin Chem Lab Med. 2006;44(12):1486-90
pubmed: 17163827
Aust N Z J Public Health. 1998 Dec;22(7):787-91
pubmed: 9889444
BMC Public Health. 2006 Jan 24;6:13
pubmed: 16433927
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):760-8
pubmed: 17001216
Rural Remote Health. 2009 Oct-Dec;9(4):1219
pubmed: 19943713
Glob Heart. 2016 Jun;11(2):243-6
pubmed: 27242094
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 2):4-24
pubmed: 13411327
J Hypertens. 2003 Nov;21(11):1983-92
pubmed: 14597836
Ann Intern Med. 2009 Nov 3;151(9):593-601
pubmed: 19884620
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
Asia Pac J Public Health. 2017 Jul;29(5):401-410
pubmed: 28516803
Soc Sci Med. 1985;20(4):381-92
pubmed: 3992282
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):138-45
pubmed: 22019549
WHO South East Asia J Public Health. 2016 Sep;5(2):89-95
pubmed: 28607234
Br Med Bull. 2010;96:23-43
pubmed: 21059733
J Clin Hypertens (Greenwich). 2016 Jan;18(1):5-6
pubmed: 26646424
Health Promot Int. 2006 Mar;21(1):13-8
pubmed: 16394026
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Int J Epidemiol. 1985 Mar;14(1):32-8
pubmed: 3872850
Circulation. 1970 Apr;41(4 Suppl):I113-22
pubmed: 5442776
Bull World Health Organ. 2001;79(10):963-70
pubmed: 11693979
BMC Public Health. 2007 Aug 23;7:216
pubmed: 17716376
PLoS One. 2015 Nov 05;10(11):e0140550
pubmed: 26540210

Auteurs

L Gamlath (L)

Ministry of Health, Colombo, Sri Lanka; formerly Director, National Institute of Health Sciences, Kalutara, Sri Lanka.

S Nandasena (S)

Office of the Regional Director of Health Services, Kalutara, Sri Lanka.

P de Silva (P)

Ministry of Health, Colombo, Sri Lanka.

S Morrell (S)

School of Public Health and Community Medicine, University of NSW, Sydney, Australia.

C Linhart (C)

School of Public Health and Community Medicine, University of NSW, Sydney, Australia.

S Lin (S)

School of Public Health and Community Medicine, University of NSW, Sydney, Australia.

A Sharpe (A)

School of Public Health and Community Medicine, University of NSW, Sydney, Australia.

S Nathan (S)

School of Public Health and Community Medicine, University of NSW, Sydney, Australia.

R Taylor (R)

School of Public Health and Community Medicine, University of NSW, Sydney, Australia. r.taylor@unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH